This study evaluates post-operative pain between different insufflation pressures during robotic-assisted sacrocolpopexy. Subjective pain and narcotic usage after surgery will be measured.

This is a prospective single-blind randomized controlled trial of adult women undergoing robotic-assisted sacrocolpopexy for pelvic organ prolapse. Each surgery will be performed by a board-certified Female Pelvic Medicine & Reconstructive Surgery (FPMRS) surgeon with a standard technique other than pneumoperitoneum level. A sacrocolpopexy for apical prolapse may be performed at the same time as a hysterectomy and other clinically indicated procedures if desired by the patient and as part of the standard of care. Patients will be stratified by hysterectomy prior to randomization. Postoperatively, patients will be evaluated with a Visual Analogue Scale (VAS) as well as prescribed narcotic analgesic use and followed up to 2 weeks.

Inclusion Criteria:

• Scheduled to have a robotic-assisted sacrocolpopexy surgery for pelvic organ prolapse.
• Age 18-90 years
• Can read and understand the consent form and consents to the procedure

Exclusion Criteria:

• Patients undergoing other procedures
• Patients who do not consent to participate.

This procedure only applies to women.

Patients will be unaware of their study group status and unaware of level of pneumoperitoneum used during their surgical procedure.